Countering pharma's expensive gaming of the drug patent system
Biomedical innovation reached a new era during the COVID-19 pandemic as drug development went into overdrive. But the ways that brand companies license their patented drugs grant them market monopoly, preventing other entities ...
Dec 6, 2022
0
38
